ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On October 21, 2019, Accuray Incorporated (the “Company”) issued a press release regarding the appointment of Suzanne Winter as the Company’s Senior Vice President, Chief Commercial Officer. A copy of this press release is included as Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this Item 7.01 disclosure, including Exhibit 99.1, is furnished to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
ACCURAY INC Exhibit
EX-99.1 2 aray-ex991_29.htm EX-99.1 aray-ex991_29.htm EXHIBIT 99.1 Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer SUNNYVALE,…
To view the full exhibit click here
About ACCURAY INCORPORATED (NASDAQ:ARAY)
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.